• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于配体的活癌细胞上 C-X-C 趋化因子受体 4(CXCR4)-配体相互作用的 NMR 研究。

Ligand-Based NMR Study of C-X-C Chemokine Receptor Type 4 (CXCR4)-Ligand Interactions on Living Cancer Cells.

机构信息

Dipartimento di Farmacia, Università di Napoli Federico II , 80131 Naples , Italy.

Istituto di Biostrutture e Bioimmagini, C.N.R. , 80134 Naples , Italy.

出版信息

J Med Chem. 2018 Apr 12;61(7):2910-2923. doi: 10.1021/acs.jmedchem.7b01830. Epub 2018 Mar 19.

DOI:10.1021/acs.jmedchem.7b01830
PMID:29522685
Abstract

Peptide-binding G protein-coupled receptors (GPCRs) are key effectors in numerous pathological and physiological pathways. The assessment of the receptor-bound conformation of a peptidic ligand within a membrane receptor such as a GPCR is of great impact for a rational drug design of more potent analogues. In this work, we applied multiple ligand-based nuclear magnetic resonance (NMR) methods to study the interaction of peptide heptamers, derived from the C-X-C Motif Chemokine 12 (CXCL12), and the C-X-C Chemokine Receptor Type 4 (CXCR4) on membranes of human T-Leukemia cells (CCRF-CEM cells). This study represents the first structural investigation reporting the receptor-bound conformation of a peptide to a GPCR directly on a living cell. The results obtained in the field of CXCL12/CXCR4 are proofs of concept, although important information for researchers dealing with the CXCR4 field arises. General application of the presented NMR methodologies is possible and surely may help to boost the development of new therapeutic agents targeting GPCRs.

摘要

肽结合 G 蛋白偶联受体(GPCR)是许多病理和生理途径中的关键效应因子。评估配体在膜受体(如 GPCR)中与受体结合的构象对于设计更有效的类似物的合理药物设计具有重要意义。在这项工作中,我们应用了多种基于配体的核磁共振(NMR)方法来研究源自 C-X-C 基序趋化因子 12(CXCL12)的肽七聚体与 C-X-C 趋化因子受体 4(CXCR4)在人 T 白血病细胞(CCRF-CEM 细胞)膜上的相互作用。这项研究代表了首次在活细胞上直接对 GPCR 进行肽结合构象的结构研究。在 CXCL12/CXCR4 领域获得的结果虽然为研究 CXCR4 领域的人员提供了重要信息,但只是概念验证。所提出的 NMR 方法的一般应用是可能的,并且肯定有助于促进针对 GPCR 的新型治疗剂的开发。

相似文献

1
Ligand-Based NMR Study of C-X-C Chemokine Receptor Type 4 (CXCR4)-Ligand Interactions on Living Cancer Cells.基于配体的活癌细胞上 C-X-C 趋化因子受体 4(CXCR4)-配体相互作用的 NMR 研究。
J Med Chem. 2018 Apr 12;61(7):2910-2923. doi: 10.1021/acs.jmedchem.7b01830. Epub 2018 Mar 19.
2
Structural analysis of CXCR4 - Antagonist interactions using saturation-transfer double-difference NMR.利用饱和转移双差核磁共振技术对CXCR4-拮抗剂相互作用进行结构分析。
Biochem Biophys Res Commun. 2015 Oct 9;466(1):28-32. doi: 10.1016/j.bbrc.2015.08.084. Epub 2015 Aug 21.
3
A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4.一种基于流式细胞术的检测方法,用于鉴定破坏荧光标记的CXC趋化因子配体12与CXC趋化因子受体4结合的化合物。
J Vis Exp. 2018 Mar 10(133):57271. doi: 10.3791/57271.
4
Structural basis for chemokine recognition by a G protein-coupled receptor and implications for receptor activation.G蛋白偶联受体识别趋化因子的结构基础及其对受体激活的影响
Sci Signal. 2017 Mar 21;10(471):eaah5756. doi: 10.1126/scisignal.aah5756.
5
Trophoblast-derived chemokine CXCL12 promotes CXCR4 expression and invasion of human first-trimester decidual stromal cells.滋养层衍生趋化因子 CXCL12 促进人早孕蜕膜基质细胞 CXCR4 的表达和浸润。
Hum Reprod. 2012 Feb;27(2):366-74. doi: 10.1093/humrep/der395. Epub 2011 Nov 23.
6
The CXCL12 (SDF-1)/CXCR4 chemokine axis: Oncogenic properties, molecular targeting, and synthetic and natural product CXCR4 inhibitors for cancer therapy.CXCL12(SDF-1)/CXCR4 趋化因子轴:致癌特性、分子靶向和用于癌症治疗的合成及天然产物 CXCR4 抑制剂。
Chin J Nat Med. 2018 Nov;16(11):801-810. doi: 10.1016/S1875-5364(18)30122-5.
7
Structural basis of the interactions between CXCR4 and CXCL12/SDF-1 revealed by theoretical approaches.理论方法揭示的CXCR4与CXCL12/SDF-1相互作用的结构基础
Mol Biosyst. 2013 Aug;9(8):2107-17. doi: 10.1039/c3mb70120d. Epub 2013 May 24.
8
Interaction of chemokine receptor CXCR4 in monomeric and dimeric state with its endogenous ligand CXCL12: coarse-grained simulations identify differences.单体和二聚体状态下趋化因子受体 CXCR4 与其内源性配体 CXCL12 的相互作用:粗粒度模拟鉴定差异。
J Biomol Struct Dyn. 2017 Feb;35(2):399-412. doi: 10.1080/07391102.2016.1145142. Epub 2016 Jul 11.
9
Functional mimetic of the G-protein coupled receptor CXCR4 on a soluble antibody scaffold.可溶性抗体支架上 G 蛋白偶联受体 CXCR4 的功能模拟物。
MAbs. 2019 May/Jun;11(4):725-734. doi: 10.1080/19420862.2019.1596703. Epub 2019 Apr 16.
10
Pharmacology of AMD3465: a small molecule antagonist of the chemokine receptor CXCR4.AMD3465的药理学:趋化因子受体CXCR4的小分子拮抗剂
Biochem Pharmacol. 2009 Oct 15;78(8):993-1000. doi: 10.1016/j.bcp.2009.06.010. Epub 2009 Jun 18.

引用本文的文献

1
Progress, Challenges and Opportunities of NMR and XL-MS for Cellular Structural Biology.核磁共振与交联质谱技术在细胞结构生物学中的进展、挑战与机遇
JACS Au. 2024 Feb 5;4(2):369-383. doi: 10.1021/jacsau.3c00712. eCollection 2024 Feb 26.
2
Modulation of the 20S Proteasome Activity by Porphyrin Derivatives Is Steered through Their Charge Distribution.卟啉衍生物通过其电荷分布来调节 20S 蛋白酶体的活性。
Biomolecules. 2022 May 24;12(6):741. doi: 10.3390/biom12060741.
3
A highly selective and potent CXCR4 antagonist for hepatocellular carcinoma treatment.
一种用于治疗肝细胞癌的高选择性和强效 CXCR4 拮抗剂。
Proc Natl Acad Sci U S A. 2021 Mar 30;118(13). doi: 10.1073/pnas.2015433118.
4
Cooperative Binding of the Cationic Porphyrin Tris-T4 Enhances Catalytic Activity of 20S Proteasome Unveiling a Complex Distribution of Functional States.三-T4 阳离子卟啉的协同结合增强 20S 蛋白酶体的催化活性,揭示了功能状态的复杂分布。
Int J Mol Sci. 2020 Sep 29;21(19):7190. doi: 10.3390/ijms21197190.
5
Structural biology of human GPCR drugs and endogenous ligands - insights from NMR spectroscopy.人源 G 蛋白偶联受体药物和内源性配体的结构生物学——来自 NMR 光谱学的见解。
Methods. 2020 Aug 1;180:79-88. doi: 10.1016/j.ymeth.2020.08.008. Epub 2020 Sep 8.
6
HOPPI-NMR: Hot-Peptide-Based Screening Assay for Inhibitors of Protein-Protein Interactions by NMR.HOPPI-NMR:基于热肽的核磁共振蛋白质-蛋白质相互作用抑制剂筛选测定法
ACS Med Chem Lett. 2020 Feb 20;11(5):1047-1053. doi: 10.1021/acsmedchemlett.9b00620. eCollection 2020 May 14.
7
Structure of the agonist 12-HHT in its BLT2 receptor-bound state.激动剂 12-HHT 在其 BLT2 受体结合状态下的结构。
Sci Rep. 2020 Feb 14;10(1):2630. doi: 10.1038/s41598-020-59571-6.
8
GPCR drug discovery: integrating solution NMR data with crystal and cryo-EM structures.GPCR 药物发现:将溶液 NMR 数据与晶体和 cryo-EM 结构相结合。
Nat Rev Drug Discov. 2019 Jan;18(1):59-82. doi: 10.1038/nrd.2018.180. Epub 2018 Nov 9.